Long R Jiao, MD, FRCS (Hepatobiliary and Pancreatic Surgery)
Hepatobiliary and Pancreatic Surgical Unit, Department of Surgery and Cancer, Imperial College, Hammersmith Hospital Campus, London, UK
Prof. Jiao is a professor of surgery, chair and consultant in hepatobiliary and pancreatic surgery (HPB) at Hammersmith Hospital Campus of Imperial College London. He is the lead surgeon in HPB Surgery at Imperial College Healthcare NHS Trust (ICHNT), and an academic Professor at Imperial College teaching and supervising both under and post graduates, MD and PhD students. He is the training programme director of the Northwest London of England for general surgery and the local postgraduate education chair at Hammersmith Hospital. He is an examiner for both MRCS of Royal Colleges of Surgeons and FRCS of Intercollegiate Examination. He has developed his research interest in pancreatic and liver diseases, wishing to improve patient outcomes through surgical innovation and translational research. His basic science work focused on MicroRNAs, circulating tumour cells (CTCs) and liver regeneration. He has investigated pathogenic mechanisms in pancreatic cystic tumours and pancreatic cancer. For the first time he described CTCs residing in organs local to pancreatic or colon cancers, and identified a few mRNAs to differentiate benign from premalignant pancreatic cystic tumours. Furthermore, he has described a range of innovative surgical techniques to improve pancreatic and liver surgery, and have introduced laparoscopic liver and pancreatic resection including laparoscopic Whipple’s. In liver surgery, he invented and described radiofrequency assisted liver partition with portal vein ligation for staged liver resection (RALPP) for major liver resection (Ann Surg 2015). In pancreatic surgery, he described longitudinal pancreaticojejunostomy following Whipple’s for pancreatic reconstruction (Arch Surg 2011), and laparoscopie Long’s sleeve pancreaticogastrostomy (LPG) for central pancreatectomy (HBSN 2016). The results of his research work have already been published in a range of high IF journals as the first or senior author in The Lancet Oncology, the Journal of Clinical Oncology, Gastroenterology and Annals of Surgery.